Black Diamond Therapeutics Inc (BDTX)
4.76
-0.02
(-0.42%)
USD |
NASDAQ |
Sep 20, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
Black Diamond Therapeutics Total Assets (Quarterly): 149.99M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 149.99M |
| March 31, 2024 | 142.52M |
| December 31, 2023 | 158.57M |
| September 30, 2023 | 172.38M |
| June 30, 2023 | 119.88M |
| March 31, 2023 | 135.58M |
| December 31, 2022 | 156.26M |
| September 30, 2022 | 180.42M |
| June 30, 2022 | 198.83M |
| March 31, 2022 | 219.48M |
| December 31, 2021 | 247.68M |
| Date | Value |
|---|---|
| September 30, 2021 | 274.13M |
| June 30, 2021 | 287.88M |
| March 31, 2021 | 313.26M |
| December 31, 2020 | 329.67M |
| September 30, 2020 | 346.44M |
| June 30, 2020 | 349.45M |
| March 31, 2020 | 362.80M |
| December 31, 2019 | 158.30M |
| September 30, 2019 | 80.73M |
| December 31, 2018 | 51.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
80.73M
Minimum
Sep 2019
362.80M
Maximum
Mar 2020
219.21M
Average
189.62M
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 36.09B |
| Ligand Pharmaceuticals Inc | 866.40M |
| Agios Pharmaceuticals Inc | 773.06M |
| ADMA Biologics Inc | 376.40M |
| AnaptysBio Inc | 427.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.96M |
| Shareholders Equity (Quarterly) | 111.02M |